| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 2 securities · passive | ||||||
|
Yarrow Bioscience, Inc.
13G/A
YARW · 92941V407
|
0.6% |
8/13/2026
Event 8/13/2026
|
||||
|
VYNE Therapeutics Inc.
13G/A
VYNE · 92941V308
|
7/17/2026
Event 6/8/2026
|
|||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.